Group A Streptococcus carbohydrate (GAC)

The Group A Streptococcus carbohydrate (GAC) is a major cell wall component of Streptococcus pyogenes, accounting for approximately 40-50% of the total cell wall mass. It consists of a poly-L-rhamnose backbone with immunodominant N-acetylglucosamine (GlcNAc) side chains, which serve as the primary basis for the Lancefield serological grouping of Group A Streptococcus (GAS). Biologically, GAC is essential for bacterial structural integrity, viability, and virulence, playing a key role in protecting the pathogen from host innate immune defenses such as antimicrobial peptides. Because GAC is highly conserved across nearly all GAS strains, it is a primary target for the development of universal vaccines and diagnostic rapid antigen tests. Therapeutic strategies focus on generating opsonizing antibodies against the GlcNAc side chains to promote bacterial clearance, though care must be taken to avoid potential autoimmune cross-reactivity with human tissues.

Other names

Group A carbohydrateGroup A Streptococcus cell wall polysaccharideLancefield Group A antigenPolyrhamnose backbone with N-acetylglucosamine side chainsGAS carbohydrate

Vaccines targeting GAC aim to induce high-titer opsonophagocytic antibodies that facilitate the clearance of Streptococcus pyogenes by the host immune system. Experimental monoclonal antibodies bind to the N-acetylglucosamine side chains of the polysaccharide to neutralize the pathogen and prevent host cell adhesion.